EUCTR2021-006781-21-BE进行中（未招募）1 期
ong-term follow-up of patients with spinal muscular atrophy Treated with OAV101 IT or OAV101 IV in Clinical Trials
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Participants eligible for inclusion in this study must meet all of the
- •following criteria:
- •1. Participated in an OAV101 clinical trial.
- •2. Written informed consent must be obtained before any assessment is
- •3. Patient/Parent/legal guardian willing and able to comply with study
- •procedures.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 260
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •There are no specific exclusion criteria for this study.
研究者
相似试验
进行中（未招募）
1 期
ong-term follow-up of patients with spinal muscular atrophy Treated with OAV101 in Clinical TrialsMedDRA version: 20.1Level: PTClassification code 10041582Term: Spinal muscular atrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersSpinal Muscular AtrophyEUCTR2021-006781-21-FRovartis Pharma AG260
进行中（未招募）
1 期
ong-term follow-up of patients with spinal muscular atrophy Treated with OAV101 in Clinical TrialsMedDRA version: 20.1Level: PTClassification code 10041582Term: Spinal muscular atrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersSpinal Muscular AtrophyEUCTR2021-006781-21-DKovartis Pharma AG260
尚未招募
3 期
ong-term follow-up of patients with spinal muscular atrophy Treated with OAV101 IT or OAV101 IV in Clinical Trialsspinal muscular atrophy1002830210029317NL-OMON56701ovartis2
进行中（未招募）
1 期
ong-term follow-up of patients with spinal muscular atrophy Treated with OAV101 IT or OAV101 IV in Clinical TrialsMedDRA version: 20.1Level: PTClassification code: 10041582Term: Spinal muscular atrophy Class: 100000004850Spinal Muscular AtrophyCTIS2024-511707-42-00ovartis Pharma AG160
尚未招募
3 期
ong-term Follow-up of Patients with Spinal Muscular Atrophy Treated with OAV101 in Clinical trialsSpinal Muscular AtrophyJPRN-jRCT2033230642Hirano Takamitsu4